Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.1.1. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.2.3. Top player positioning

3.3. Porter's five forces analysis
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in popularity of personalized medicines
3.4.1.2. Upsurge in R&D expenditure
3.4.1.3. Technological advancements associated with proteomics components

3.4.2. Restraints

3.4.2.1. High costs associated with proteomics components
3.4.2.2. Dearth of skilled professionals

3.4.3. Opportunities

3.4.3.1. Lucrative opportunities associated with biomarker identification
3.4.3.2. Developments in mass spectrometry-based proteomics

Chapter: 4: PROTEOMICS MARKET, BY COMPONENT

4.1. Overview

4.1.1. Market size and forecast

4.2. Reagents

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Microarray

4.2.3.1. Market size and forecast

4.2.4. Spectrometry

4.2.4.1. Market size and forecast

4.2.5. X-ray crystallography

4.2.5.1. Market size and forecast

4.2.6. Chromatography

4.2.6.1. Market size and forecast

4.2.7. Electrophoresis

4.2.7.1. Market size and forecast

4.2.8. Immunoassay

4.2.8.1. Market size and forecast

4.2.9. Protein fractionation reagents

4.2.9.1. Market size and forecast

4.2.10. Market analysis, by country

4.3. Instruments

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Microarray

4.3.3.1. Market size and forecast

4.3.4. Spectrometry

4.3.4.1. Market size and forecast

4.3.4.1.1. Mass spectrometry

4.3.4.1.1.1. Market size and forecast

4.3.4.1.2. NMR spectrometry

4.3.4.1.2.1. Market size and forecast

4.3.5. Chromatography

4.3.5.1. Market size and forecast

4.3.5.1.1. HPLC systems

4.3.5.1.1.1. Market size and forecast

4.3.5.1.2. Ion chromatography

4.3.5.1.2.1. Market size and forecast

4.3.5.1.3. Affinity chromatography

4.3.5.1.3.1. Market size and forecast

4.3.5.1.4. Supercritical fluid chromatography

4.3.5.1.4.1. Market size and forecast

4.3.6. Electrophoresis

4.3.6.1. Market size and forecast

4.3.7. Surface plasmon resonance

4.3.7.1. Market size and forecast

4.3.8. X-ray crystallography

4.3.8.1. Market size and forecast

4.3.9. Protein fractionation systems

4.3.9.1. Market size and forecast

4.3.10. Market analysis, by country

4.4. Services

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

Chapter: 5: PROTEOMICS MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Drug discovery

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Disease diagnosis

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Others

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

Chapter: 6: PROTEOMICS MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country

6.2.2.1. U.S.

6.2.2.1.1. U.S. proteomics market, by component
6.2.2.1.2. U.S. proteomics market, by application

6.2.2.2. Canada

6.2.2.2.1. Canada proteomics market, by component
6.2.2.2.2. Canada proteomics market, by application

6.2.2.3. Mexico

6.2.2.3.1. Mexico proteomics market, by component
6.2.2.3.2. Mexico proteomics market, by application

6.2.3. North America proteomics market, by component
6.2.4. North America proteomics market, by application

6.3. Europe

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country

6.3.2.1. Germany

6.3.2.1.1. Germany proteomics market, by component
6.3.2.1.2. Germany proteomics market, by application

6.3.2.2. France

6.3.2.2.1. France proteomics market, by component
6.3.2.2.2. France proteomics market, by application

6.3.2.3. UK

6.3.2.3.1. UK proteomics market, by component
6.3.2.3.2. UK proteomics market, by application

6.3.2.4. Italy

6.3.2.4.1. Italy proteomics market, by component
6.3.2.4.2. ITALY proteomics market, by application

6.3.2.5. Spain

6.3.2.5.1. Spain proteomics market, by component
6.3.2.5.2. Spain proteomics market, by application

6.3.2.6. Rest of Europe

6.3.2.6.1. Rest of Europe proteomics market, by component
6.3.2.6.2. Rest of Europe proteomics market, by application

6.3.3. Europe proteomics market, by component
6.3.4. Europe proteomics market, by application

6.4. Asia-Pacific

6.4.1. Key market trends, growth factors, and opportunities

6.4.1.1. Japan

6.4.1.1.1. Japan proteomics market, by component
6.4.1.1.2. Japan proteomics market, by application

6.4.1.2. China

6.4.1.2.1. China proteomics market, by component
6.4.1.2.2. China proteomics market, by application

6.4.1.3. India

6.4.1.3.1. India proteomics market, by component
6.4.1.3.2. India proteomics market, by application

6.4.1.4. Australia

6.4.1.4.1. Australia proteomics market, by component
6.4.1.4.2. Australia proteomics market, by application

6.4.1.5. South Korea

6.4.1.5.1. South Korea proteomics market, by component
6.4.1.5.2. South Korea proteomics market, by application

6.4.1.6. Rest of Asia-Pacific

6.4.1.6.1. Rest of Asia-Pacific proteomics market, by component
6.4.1.6.2. Rest of Asia-Pacific proteomics market, by application

6.4.2. Asia-Pacific proteomics market, by component
6.4.3. Asia-Pacific proteomics market, by application

6.5. LAMEA

6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country

6.5.2.1. Brazil

6.5.2.1.1. Brazil proteomics market, by component
6.5.2.1.2. Brazil proteomics market, by application

6.5.2.2. Saudi Arabia

6.5.2.2.1. Saudi Arabia proteomics market, by component
6.5.2.2.2. Saudi Arabia proteomics market, by application

6.5.2.3. South Africa

6.5.2.3.1. South Africa proteomics market, by component
6.5.2.3.2. South Africa proteomics market, by application

6.5.2.4. Rest of LAMEA

6.5.2.4.1. Rest of LAMEA proteomics market, by component
6.5.2.4.2. Rest of LAMEA proteomics market, by application

6.5.3. LAMEA proteomics market, by component
6.5.4. LAMEA proteomics market, by application

Chapter: 7: COMPANY PROFILES

7.1. AGILENT TECHNOLOGIES, INC.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments

7.2. DANAHER CORPORATION (BECKMAN COULTER, INC.)

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance

7.3. LI-COR, INC.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio

7.4. PERKINELMER INC.

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. THERMO FISHER SCIENTIFIC, INC.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments

7.6. HORIBA, LTD.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance

7.7. BIO-RAD LABORATORIES, INC.

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product type Portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments

7.8. BRUKER CORPORATION (BECKMAN COULTER, INC.)

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product type portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments

7.9. GE HEALTHCARE (GENERAL ELECTRIC)

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance

7.10. WATERS CORPORATION (BECKMAN COULTER, INC.)

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product type portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments